Investors take note—big pharma has no physical assets to develop drugs, nor the skills required
Hedley's interview with TrialSite News
Investors hold the key to stopping big pharma antics
There is one sure way to get the attention of big pharma—investors unhappy with the performance of their hard-earned cash injections (excuse the pun!).
The previous post below should have given you a flavour of the risks and potholes that scatter the big pharma landscape.
My TrialSite News interview with Megan Redshaw laid flesh on the bones of this love affair that has taken big pharma to the edge of failure. Investors need to hear about that. They may want to put their money elsewhere. In doing that, the world will be a far better place without it.
Drug Development Expert Says Pharma’s 40-Year Love Affair with Outsourcing Must End
Watch the video here.
Don’t let me spoil your fun by telling you more. All I would ask is if you feel moved to share the video on YouTube, that would be a wonderful thing :O).
Hedley